Laboratory Corporation of America Holdings
NYSE:LH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Laboratory Corporation of America Holdings
EPS (Diluted)
Laboratory Corporation of America Holdings
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
EPS (Diluted)
$10
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
9%
|
|
|
DaVita Inc
NYSE:DVA
|
EPS (Diluted)
$9
|
CAGR 3-Years
19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
23%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
EPS (Diluted)
$8
|
CAGR 3-Years
3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
6%
|
|
|
CVS Health Corp
NYSE:CVS
|
EPS (Diluted)
$1
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
EPS (Diluted)
$22
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
11%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
EPS (Diluted)
-$3
|
CAGR 3-Years
20%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
Glance View
Laboratory Corporation of America Holdings, commonly known as LabCorp, stands as a formidable player in the world of healthcare diagnostics. Emerging from a confluence of scientific innovation and business acumen, LabCorp has carved a niche within the intricate fabric of healthcare services. Since its inception, the company has excelled in offering a comprehensive suite of laboratory-based tests and services, empowering physicians and healthcare providers with critical insights needed for effective patient diagnosis and management. With its headquarters in Burlington, North Carolina, LabCorp operates a vast network of laboratories and patient service centers across the nation, providing services that range from routine blood work to sophisticated genomic testing. The essence of LabCorp’s business model lies in seamless integration across the healthcare continuum, driving both operational efficiency and profitability. Fundamentally, the company generates revenue by performing diagnostic tests on patient specimens, serving hospitals, managed care organizations, physician offices, and governmental agencies. As healthcare systems evolve towards precision medicine, LabCorp has harnessed emerging technologies and innovations like genomic testing to enhance its service offerings. This expansion not only aligns with changing healthcare paradigms but also fortifies its market leadership. By continually investing in research and development, LabCorp keeps its services at the cutting edge, ensuring steady growth and resilience in an ever-changing healthcare landscape.
See Also
What is Laboratory Corporation of America Holdings's EPS (Diluted)?
EPS (Diluted)
10.5
USD
Based on the financial report for Dec 31, 2025, Laboratory Corporation of America Holdings's EPS (Diluted) amounts to 10.5 USD.
What is Laboratory Corporation of America Holdings's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
9%
Over the last year, the EPS (Diluted) growth was 18%. The average annual EPS (Diluted) growth rates for Laboratory Corporation of America Holdings have been -9% over the past three years , -8% over the past five years , and 9% over the past ten years .